The FDA says people may be subject to dosing errors.
The U.S. Food and Drug Administration has issued a new warning about a popular medication used for weight loss.
The agency said the dosing errors are a result of both patients measuring and self-administering incorrect doses of the medication, as well as health care providers "miscalculating" doses of the medication. Semaglutide is the active ingredient in three FDA-approved medications, Wegovy, Ozempic and Rybelsus.
The warning came as many people reported turning to compounding pharmacies to get cheaper doses of semaglutide.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns website over unlawful sale of weight-loss drugsThe U.S. Food and Drug Administration said on Tuesday it had warned a website called ozempen.com against unlawfully selling versions of Novo Nordisk's weight-loss drugs.
Read more »
FDA Warns of 48 Illnesses, One Death Linked to Diamond Shruumz EdiblesThe U.S. Food and Drug Administration said Tuesday it is now investigating nearly 50 illnesses and one death that may be linked to eating Diamond Shruumz edibles.
Read more »
FDA warns WA residents of microdosing products linked to severe illnessThe FDA says anyone with “Diamond Shruumz' products should destroy and discard them after multiple people developed severe illness after consuming the products.
Read more »
FDA warns Diamond Shruumz still on shelves despite recall, hospitalizationsAt least 36 have been hospitalized after eating the mushroom 'edibles.'
Read more »
FDA Warns of THC-Laced Edibles That Look Like Common Children's SnacksThe FDA issued a warning that THC edibles pose a risk to children, with names and packaging that deliberately resemble popular children's cookies and snacks.
Read more »
'Stop Using' Unsafe Kitchen Spice, FDA Warns'Based on FDA's assessment, consuming this product is likely to contribute to elevated levels of lead in the blood,' the FDA states.
Read more »